| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,053 |
15,519 |
$4.95M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,171 |
9,105 |
$2.78M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,628 |
5,002 |
$1.30M |
| G0378 |
Hospital observation service, per hour |
1,299 |
1,116 |
$486K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,599 |
1,516 |
$385K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,906 |
2,778 |
$325K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,806 |
2,684 |
$323K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,098 |
6,959 |
$300K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,700 |
7,455 |
$176K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,234 |
2,973 |
$166K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,193 |
2,759 |
$158K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,712 |
3,268 |
$154K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,905 |
5,231 |
$153K |
| OP370 |
|
1,692 |
1,592 |
$133K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
172 |
86 |
$131K |
| 97010 |
|
3,120 |
1,035 |
$109K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,406 |
2,189 |
$98K |
| OP250 |
|
47,225 |
21,360 |
$96K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
638 |
595 |
$78K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,824 |
6,672 |
$75K |
| 71046 |
Radiologic examination, chest; 2 views |
3,788 |
3,577 |
$73K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,484 |
1,324 |
$65K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,035 |
11,189 |
$61K |
| OP710 |
|
1,694 |
1,594 |
$59K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
157 |
152 |
$56K |
| 71045 |
Radiologic examination, chest; single view |
3,401 |
3,060 |
$49K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
852 |
814 |
$49K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,534 |
10,104 |
$49K |
| 73564 |
|
1,148 |
1,104 |
$44K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,157 |
2,594 |
$44K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
876 |
803 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,246 |
2,960 |
$31K |
| 73630 |
|
1,356 |
1,280 |
$28K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,289 |
389 |
$27K |
| 73030 |
|
1,071 |
1,008 |
$27K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
340 |
326 |
$26K |
| 97161 |
|
757 |
714 |
$24K |
| 72110 |
|
442 |
424 |
$24K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
852 |
809 |
$23K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
393 |
355 |
$23K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
190 |
176 |
$22K |
| 73130 |
|
1,129 |
1,069 |
$22K |
| 96376 |
|
694 |
587 |
$21K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
205 |
197 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
734 |
696 |
$19K |
| 76770 |
|
195 |
191 |
$19K |
| 84484 |
|
4,323 |
3,424 |
$17K |
| 73610 |
|
961 |
901 |
$17K |
| 97162 |
|
359 |
351 |
$15K |
| 80053 |
Comprehensive metabolic panel |
2,497 |
2,256 |
$14K |
| 76830 |
Ultrasound, transvaginal |
168 |
163 |
$13K |
| 81001 |
|
8,536 |
7,766 |
$11K |
| 73110 |
|
633 |
575 |
$11K |
| 93971 |
|
85 |
81 |
$11K |
| 82962 |
|
4,247 |
3,082 |
$11K |
| 82553 |
|
3,699 |
3,141 |
$11K |
| 76801 |
|
120 |
111 |
$10K |
| 83880 |
|
1,157 |
1,037 |
$10K |
| 72100 |
|
326 |
321 |
$10K |
| 0012A |
|
400 |
399 |
$10K |
| 82550 |
|
3,893 |
3,300 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
940 |
903 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,545 |
1,469 |
$9K |
| 0011A |
|
397 |
396 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
155 |
152 |
$9K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,689 |
1,153 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,053 |
971 |
$8K |
| 84703 |
|
5,625 |
5,170 |
$8K |
| 80076 |
|
3,262 |
2,953 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,045 |
1,422 |
$8K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
15 |
14 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
939 |
903 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
12 |
12 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
3,629 |
2,755 |
$7K |
| 83735 |
|
2,711 |
2,238 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
587 |
560 |
$6K |
| 83690 |
|
3,238 |
2,888 |
$6K |
| OP621 |
|
2,047 |
1,941 |
$6K |
| 73502 |
|
241 |
232 |
$6K |
| OP272 |
|
386 |
358 |
$5K |
| 86850 |
|
689 |
626 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
43 |
40 |
$5K |
| 85610 |
|
1,636 |
1,449 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
310 |
138 |
$5K |
| 85027 |
|
794 |
741 |
$5K |
| 73562 |
|
323 |
316 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,492 |
1,389 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
715 |
618 |
$4K |
| 83605 |
|
471 |
421 |
$4K |
| 86900 |
|
736 |
669 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,064 |
1,028 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
117 |
94 |
$3K |
| 85730 |
|
961 |
863 |
$2K |
| 86901 |
|
735 |
668 |
$2K |
| 87081 |
|
587 |
576 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
12 |
12 |
$2K |
| 82248 |
|
398 |
365 |
$2K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
140 |
135 |
$2K |
| 85379 |
|
859 |
810 |
$2K |
| 0071A |
|
43 |
43 |
$2K |
| 97014 |
|
133 |
40 |
$2K |
| 90715 |
|
414 |
389 |
$2K |
| 87040 |
|
245 |
194 |
$1K |
| 80061 |
Lipid panel |
289 |
259 |
$1K |
| 0072A |
|
34 |
34 |
$1K |
| 0002A |
|
35 |
35 |
$1K |
| 0001A |
|
30 |
30 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
133 |
78 |
$1K |
| 70486 |
|
28 |
26 |
$1K |
| 99215 |
Prolong outpt/office vis |
37 |
15 |
$916.20 |
| 74018 |
|
50 |
45 |
$855.30 |
| 87186 |
|
204 |
191 |
$795.24 |
| 97116 |
|
47 |
28 |
$773.94 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
790 |
570 |
$760.80 |
| J2060 |
Injection, lorazepam, 2 mg |
189 |
167 |
$626.80 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40 |
37 |
$598.34 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
51 |
47 |
$503.37 |
| 77080 |
|
12 |
12 |
$464.67 |
| 0013A |
|
19 |
18 |
$455.48 |
| 72050 |
|
12 |
12 |
$428.65 |
| 84702 |
|
92 |
81 |
$399.43 |
| 73080 |
|
27 |
26 |
$367.27 |
| 84100 |
|
438 |
368 |
$365.00 |
| 72070 |
|
15 |
15 |
$364.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,040 |
1,813 |
$364.01 |
| 71250 |
|
15 |
14 |
$358.23 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
250 |
222 |
$321.70 |
| 81003 |
|
65 |
65 |
$294.11 |
| 87077 |
|
54 |
52 |
$267.83 |
| 74022 |
|
14 |
12 |
$264.89 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16 |
12 |
$238.61 |
| 82803 |
|
99 |
86 |
$236.94 |
| OP255 |
|
33 |
29 |
$203.37 |
| 87088 |
|
141 |
137 |
$174.78 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,859 |
1,634 |
$158.09 |
| 88342 |
|
26 |
24 |
$146.48 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
768 |
703 |
$134.60 |
| J2704 |
Injection, propofol, 10 mg |
958 |
913 |
$115.25 |
| 87420 |
|
63 |
59 |
$114.73 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
839 |
522 |
$110.09 |
| 82728 |
|
14 |
14 |
$94.45 |
| 12011 |
|
12 |
12 |
$68.61 |
| 91301 |
|
736 |
710 |
$65.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
822 |
778 |
$48.74 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
429 |
398 |
$26.99 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
640 |
550 |
$25.02 |
| 83540 |
|
13 |
12 |
$22.36 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
277 |
242 |
$14.03 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
368 |
278 |
$12.47 |
| 86140 |
|
13 |
13 |
$12.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
95 |
93 |
$8.86 |
| J1630 |
Injection, haloperidol, up to 5 mg |
97 |
77 |
$7.57 |
| 85652 |
|
14 |
14 |
$7.50 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
155 |
129 |
$7.44 |
| C9113 |
Injection, pantoprazole sodium, per vial |
27 |
26 |
$5.58 |
| 91300 |
|
101 |
91 |
$3.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
13 |
13 |
$2.73 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
14 |
$2.00 |
| OP258 |
|
13 |
12 |
$1.22 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
212 |
133 |
$1.00 |
| 91307 |
|
88 |
74 |
$0.00 |